| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 06/20/2006 | US7064212 Dicationic viologens, such as methyl viologen and benzyl viologen, associated with anions selected from bis(trifluoro-methyl(or perfluoroethyl)sulfonyl)imide and tris(trifluoro-methylsulfonyl)methide; soluble in quat ammonium melts |
| 06/20/2006 | US7064139 Prevention reproduction of virus |
| 06/20/2006 | US7064128 Preferentially substituted calcium channel blockers |
| 06/20/2006 | US7064123 substituted acetamides; uses for treating diseases including arthritis, muscular dystrophy, inflammation, tumor invasion, glomerulonephritis, malaria, periodontal disease, and metachromatic leukodystrophy |
| 06/20/2006 | US7064118 Cholinergic ligands of the nicotinic acetyl choline receptors; modulators; nervous system disordes, analgesics; smooth muscle contraction; antiinflammatory agents; drug abuse, including smoking; Alzheimer's disease; Parkinson's disease; cognition |
| 06/20/2006 | US7063903 Photoactive lanthanide complexes with phosphine oxides, phosphine oxide-sulfides, pyridine N-oxides, and phosphine oxide-pyridine N-oxides, and devices made with such complexes |
| 06/20/2006 | CA2135480C Trisubstituted phenyl derivatives as phosphodiesterase inhibitors and processes for their preparation |
| 06/20/2006 | CA2121523C Sulfonamide derivatives |
| 06/15/2006 | WO2006063294A2 Novel inhibitors of histone deacetylase for the treatment of disease |
| 06/15/2006 | WO2006062979A1 Herbicidal 6-cyclopropyl-substitute 4-aminopicolinic acid derivatives |
| 06/15/2006 | WO2006062580A1 Indane amides with antiproliferative activity |
| 06/15/2006 | WO2006062201A1 Method for producing thiocarbamate derivative |
| 06/15/2006 | WO2006062093A1 Novel anthranilic acid derivative or salt thereof |
| 06/15/2006 | WO2006061715A2 Methylene inhibitors of matrix metalloproteinase |
| 06/15/2006 | WO2006061427A1 5-amino-4-hydroxy-2-isopropyl-7-[4-methoxy-3-(3-methoxypropxy)benzyl]-8-methylnonanamides |
| 06/15/2006 | WO2006061215A2 2-alkyl-cycloalk(en)yl-carboxamides |
| 06/15/2006 | WO2006061193A1 Indenyl derivatives and use thereof for the treatment of neurological disorders |
| 06/15/2006 | WO2006044379A3 Novel curcumin analogues and uses thereof |
| 06/15/2006 | WO2006010775A8 Tyrosine derivatives as ppar-gamma-modulators |
| 06/15/2006 | WO2006003494A3 Piperidine derivatives and their use as insecticides, acaricides, molluscicides or nematicides |
| 06/15/2006 | WO2005110399A3 Zinc-binding groups for metalloprotein inhibitors |
| 06/15/2006 | WO2005085188A3 Compounds and methods for anti-tumor therapy |
| 06/15/2006 | US20060128996 Compositions containing Ionic liquids and uses thereof, especially in organic synthesis |
| 06/15/2006 | US20060128965 chemical intermediates to insecticides and anticoagulant inhibitors of factor Xa having a 1-halophenyl-3-trifluoromethylpyrazole moeity; 1-(1-chloro-2-phenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxylic acid |
| 06/15/2006 | US20060128957 Fluorous tagging and scavenging reactants and methods of synthesis and use thereof |
| 06/15/2006 | US20060128765 2-(Bicyclo)alkylamino-derivatives as mediators of chronic pain and inflammation |
| 06/15/2006 | US20060128762 Medicinal composition and method for treating malignant tumor and utilization thereof |
| 06/15/2006 | US20060128757 Pyridine derivatives useful as cyclooxygenase inhibitor |
| 06/15/2006 | US20060128750 Targeting chemokine receptors and interfere with the binding of the natural ligand thereto; antagonists or agonists; protecting target cells from HIV infection; treating HIV or FIV infected patients |
| 06/15/2006 | US20060128734 N-(4-(4-(4-hydroxyphenylamino)-pyrimidin-6-yl)-oxyphenyl)-N'-(3-trifluoromethylphenyl)-urea; |
| 06/15/2006 | US20060128692 Non nucleoside reverse transcriptase inhibitors |
| 06/15/2006 | US20060128684 Anthranilic acid amide derivatives and their pharmaceutical use |
| 06/15/2006 | US20060128674 Induce the biosynthesis of cytokines such as interferon and tumor necrosis factor; antiviral and antitumor agents |
| 06/15/2006 | US20060128670 Pesticidally active ketone and oxime derivatives |
| 06/15/2006 | US20060128662 Novel compounds for treatment of obesity |
| 06/15/2006 | US20060127306 Radioactively labelled amino acid analogues, their preparation and use |
| 06/15/2006 | CA2591332A1 Methylene inhibitors of matrix metalloproteinase |
| 06/15/2006 | CA2590252A1 5-amino-4-hydroxy-2-isopropyl-7-[4-methoxy-3-(3-methoxypropxy)benzyl]-8-methylnonanamides |
| 06/15/2006 | CA2590220A1 2-alkyl-cycloalk(en)yl-carboxamides |
| 06/15/2006 | CA2589831A1 Indenyl derivatives and use thereof for the treatment of neurological disorders |
| 06/15/2006 | CA2588633A1 Novel anthranilic acid derivative or salt thereof |
| 06/15/2006 | CA2584307A1 Indane amides with antiproliferative activity |
| 06/14/2006 | EP1669348A1 Novel antifungal agent comprising heterocyclic compound |
| 06/14/2006 | EP1669345A1 Ester derivative and medicinal use thereof |
| 06/14/2006 | EP1669069A1 Compounds effecting glukokinase |
| 06/14/2006 | EP1669068A1 Compounds effecting Glucokinase |
| 06/14/2006 | EP1667997A1 Pyrimidine and pyridine derivatives useful as hmg-coa reductase inhibitors and method of preparation thereof |
| 06/14/2006 | EP1667955A2 Cycloalkylidene compounds as modulators of the estrogen receptor |
| 06/14/2006 | EP1309315B1 Rapidly disintegrating oral formulation of valdecoxib |
| 06/14/2006 | EP1261338B1 Compositions and methods for treatment of epilepsy |
| 06/14/2006 | CN1787998A Method for producing bipyridinium compound |
| 06/14/2006 | CN1787989A Imino ether derivative compounds and drugs containing the compounds as the active ingredient |
| 06/14/2006 | CN1259307C Acylated indanyl amines and their use as pharmaceuticals |
| 06/13/2006 | US7060850 Fluorous tagging and scavenging reactants and methods of synthesis and use thereof |
| 06/13/2006 | US7060826 Central nervous system disorders; Alzheimer's disease; huntington's disease; Parkinson's disease; attention deficit disorders; schizophrenia; Tourette's syndrome |
| 06/13/2006 | US7060717 Phosphodiesterase inhibitor; antiinflammatory agents; antiallergens; respiratory system disorders; wound healing agents |
| 06/13/2006 | US7060716 Compound containing two triple bonds |
| 06/13/2006 | US7060715 Substituted pyridines as selective cyclooxygenase-2 inhibitors |
| 06/13/2006 | US7060700 Amide derivatives useful as inhibitors of the production of cytokines |
| 06/13/2006 | US7060664 Organic compounds |
| 06/13/2006 | US7060110 Chromatic direct dyes |
| 06/13/2006 | CA2260777C Pentafluorobenzenesulfonamides and analogs |
| 06/13/2006 | CA2180008C Cyclopentane(ene) heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents |
| 06/13/2006 | CA2158981C Herbicidal heterocyclic-substituted pyridines |
| 06/08/2006 | WO2006060810A1 Sulfonamide compounds as cysteine protease inhibitors |
| 06/08/2006 | WO2006060108A1 N-(pyridin-3-yl)-2-phenylbutanamides as androgen receptor modulators |
| 06/08/2006 | WO2006059778A1 Substituted pyridone derivative |
| 06/08/2006 | WO2006059149A1 Arylsulfonylnaphthalene derivatives as 5ht2a antagonists |
| 06/08/2006 | WO2006059103A2 Pyridine based compounds useful as intermediates for pharmaceutical or agricultural end-products |
| 06/08/2006 | WO2006058700A1 Acetamide compounds as fungicides |
| 06/08/2006 | WO2006058649A1 3-substituted pyridine derivatives as h3 antagonists |
| 06/08/2006 | WO2006044602A9 Diphenyl substituted alkanes as flap inhiibitors |
| 06/08/2006 | WO2006028972A3 Mercaptoamides as histone deacetylase inhibitors |
| 06/08/2006 | WO2006010095A3 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors |
| 06/08/2006 | WO2005120505A3 Tetrahydropyranyl cyclopentyl tetrahy-dropyridopyridine modulators of chemokine receptor activity |
| 06/08/2006 | US20060123404 Computer program code size partitioning system and method for multiple memory multi-processing systems |
| 06/08/2006 | US20060122390 Boronic ester and acid compounds, synthesis and uses |
| 06/08/2006 | US20060122383 Antiviral methods employing double esters of 2', 3'-dideoxy-3'-fluoroguanosine |
| 06/08/2006 | US20060122269 Compounds that abrogate DNA damage induced cell cycle G2 checkpoint and/or augment anti-cancer activity of DNA-damaging treatments |
| 06/08/2006 | US20060122268 Such as N1-(1-cyanocyclopropyl)-4-fluoro-N2-((1S)-2,2,2-trifluoro-1-(4' -(methylsulfonyl)-1,1'-biphenyl-4-yl) ethyl)-L-leucinamide; for treating osteoporosis and other bone loss disorders |
| 06/08/2006 | US20060122242 2-Aryloxy-2-arylalkanoic acids for diabetes and lipid disorders |
| 06/08/2006 | US20060122239 Lipid diseases; metabolism diosrders; antiproliferative agents |
| 06/08/2006 | US20060122238 Hydroxybenzoate salts of metanicotine compounds |
| 06/08/2006 | US20060122237 N-methyl-5-(5-isopropoxy-3-pyridinyl)-4-penten-2-amine p-hydroxybenzoate; compounds can activate nicotinic receptor and can modulate neurotransmitter secretion; neuroprotective agents; side effects reduction; pains; easy to remove impurities; heck coupling reaction; CNS disorders; inflammatory disorders |
| 06/08/2006 | US20060122236 Substituted biaryl-carboxylate derivatives |
| 06/08/2006 | US20060122231 Such as N-(4-tert-butylphenyl)-4-(2-pyridinyl)benzamide for treatment of urinary incontinence, pain, inflammatory thermal hyperalgesia, and/or bladder overactivity |
| 06/08/2006 | US20060122214 Agent for prophylaxis and treatment of angiostenosis |
| 06/08/2006 | US20060122193 E.g., Methyl 3-[(4-[(diethylamino)carbonyl]phenyl)(4-benzyl-piperazin-1-yl)methyl]phenylcarbamate and Methyl 3-{(S)-{4-[(diethylamino)carbonyl]phenyl}[4-(1,3-thiazol-4-ylmethyl)piperazin-1-yl]methyl}phenylcarbamate |
| 06/08/2006 | US20060122183 Synergistic; side effect reduction; melanomas; toxicity; 2,5-Dimethoxythiobenzoic Acid N-methylhydrazine; anticancer |
| 06/08/2006 | US20060122100 Melanin extinguisher |
| 06/08/2006 | US20060122062 2,2,2-trifluoro-N-[5-methyl-1-(3-trifluoromethylphenyl)-2(1H)-pyridinylidene]-acetamide; herbicides; 1-phenylazinethione and 1-phenylchloroazinium intermediates; 1-phenylpyridones: 5-methyl-1-(3-trifluoromethyl-phenyl)-2(1H)-pyridinone |
| 06/08/2006 | US20060119254 Neutral metallic dendrimer complexes |
| 06/08/2006 | CA2589010A1 Biaryloxymethylarene carboxylic acids |
| 06/08/2006 | CA2588867A1 Substituted pyridone derivative |
| 06/08/2006 | CA2588864A1 Arylsulfonylnaphthalene derivatives as 5ht2a antagonists |
| 06/08/2006 | CA2588466A1 Use of atazanavir for improving the pharmacokinetics of drugs metabolized by ugt1a1 |
| 06/08/2006 | CA2588463A1 3-substituted pyridine derivatives as h3 antagonists |
| 06/08/2006 | CA2585276A1 N-(pyridin-3-yl)-2-phenylbutanamides as androgen receptor modulators |
| 06/08/2006 | CA2558647A1 Insecticidal n-substituted sulfoximines |
| 06/07/2006 | EP1666467A1 11Beta-HSD1 Inhibitors |